France Confirms First Human Case of Livestock Virus

France reported the world's first human infection with the Shamonda virus in an immunocompromised hospital patient who died in Lyon earlier in October.

The victim, a man in his 60s, was receiving treatment for a serious underlying illness when he developed neurological complications linked to the pathogen.

Health officials suspect the patient contracted the pathogen from an insect bite while residing in eastern France, where animal infections surfaced recently.

The detection marks a major scientific milestone because the virus previously appeared only in livestock such as cattle, sheep, goats and horses.

“Based on current information and knowledge of the transmission of closely related viruses, this is an isolated human case and it is unlikely to lead to wider spread at this time,” said the World Health Organization.

The pathogen was first discovered in Nigeria in the mid-1960s and has since circulated across parts of Africa and Asia without any documented human infections until now.

European health agencies note that the virus arrived in Western Europe this summer, with livestock cases identified in Germany, Switzerland, France and several other nations.

Specialists state that tiny insects known as biting midges serve as the primary vehicle for spreading the disease among animals.

“We are clearly dealing with a case that is unprecedented from a scientific and virological point of view,” said Grégory Emery, head of France's health directorate.

Emery added that authorities found no evidence of human-to-human transmission and maintained that the general population faces no risk.

“This is a very special case,” said Tamás Bakonyi, principal expert on vector-borne and zoonotic diseases at the European Centre for Disease Prevention and Control.

Bakonyi added that the patient's leukemia left him severely immunocompromised, which allowed the infection to progress differently than it would in a healthy individual.

Researchers are still attempting to determine whether the pathogen directly caused the death or merely contributed to the patient's existing decline.

Investigators continue to trace the exact transmission route and assess potential public health implications alongside international partners.